Omeros (OMER) EBIAT (2010 - 2026)
Omeros recorded quarterly EBIAT of $51.2 million in Q1 2026, down 40.72% quarter-over-quarter from $86.4 million in Q4 2025, and up 253.16% year-over-year from $14.5 million in Q1 2025.
Omeros' EBIAT history runs 17 years deep, the most recent figure standing at $51.2 million for Q1 2026.
- In Q1 2026, EBIAT rose 253.16% year-over-year to $51.2 million; the TTM figure through Mar 2026 stood at $81.4 million (up 159.24% YoY), while the FY2025 annual figure was -$3.4 million, up 97.86% from the prior year.
- EBIAT came in at $51.2 million for Q1 2026 at Omeros, down from $86.4 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $86.4 million in Q4 2025 to a low of -$56.0 million in Q2 2024.
- A 5-year average of -$23.9 million and a median of -$33.7 million in 2023 frame the typical range for EBIAT.
- Across the five-year window, EBIAT plunged 116.41% in 2022 and jumped 905.91% in 2025, its largest moves.
- Omeros' EBIAT stood at -$46.0 million in 2022, then increased by 14.68% to -$39.3 million in 2023, then surged by 72.7% to -$10.7 million in 2024, then surged by 905.91% to $86.4 million in 2025, then sank by 40.72% to $51.2 million in 2026.
- According to Business Quant data, EBIAT over the past three periods registered $51.2 million, $86.4 million, and -$30.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 51.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.25 Mn |
| Dec 31, 2025 | 86.45 Mn |
| Sep 30, 2025 | -30.92 Mn |
| Jun 30, 2025 | -25.42 Mn |
| Mar 31, 2025 | -33.46 Mn |
| Dec 31, 2024 | -10.73 Mn |
| Sep 30, 2024 | -37.11 Mn |
| Jun 30, 2024 | -56.04 Mn |
| Mar 31, 2024 | -37.18 Mn |
| Dec 31, 2023 | -39.29 Mn |
| Sep 30, 2023 | -37.75 Mn |
| Jun 30, 2023 | -37.29 Mn |
| Mar 31, 2023 | -33.70 Mn |
| Dec 31, 2022 | -46.05 Mn |
| Sep 30, 2022 | -54.79 Mn |
| Jun 30, 2022 | -30.85 Mn |
| Mar 31, 2022 | -33.01 Mn |
| Dec 31, 2021 | 280.62 Mn |
| Sep 30, 2021 | -44.28 Mn |
| Jun 30, 2021 | -28.59 Mn |
| Mar 31, 2021 | -35.09 Mn |
| Dec 31, 2020 | -37.27 Mn |
| Sep 30, 2020 | -38.46 Mn |
| Jun 30, 2020 | -33.29 Mn |
| Mar 31, 2020 | -29.03 Mn |
| Dec 31, 2019 | -29.23 Mn |
| Sep 30, 2019 | -16.46 Mn |
| Jun 30, 2019 | -14.45 Mn |
| Mar 31, 2019 | -24.35 Mn |
| Dec 31, 2018 | -23.53 Mn |
| Sep 30, 2018 | -39.47 Mn |
| Jun 30, 2018 | -33.70 Mn |
| Mar 31, 2018 | -30.05 Mn |
| Dec 31, 2017 | -16.55 Mn |
| Sep 30, 2017 | -7.48 Mn |
| Jun 30, 2017 | -14.36 Mn |
| Mar 31, 2017 | -15.09 Mn |
| Dec 31, 2016 | -19.63 Mn |
| Sep 30, 2016 | -13.96 Mn |
| Jun 30, 2016 | -12.61 Mn |
| Mar 31, 2016 | -20.54 Mn |
| Dec 31, 2015 | -19.83 Mn |
| Sep 30, 2015 | -19.92 Mn |
| Jun 30, 2015 | -16.68 Mn |
| Mar 31, 2015 | -18.67 Mn |
| Dec 31, 2014 | -20.71 Mn |
| Sep 30, 2014 | -18.33 Mn |
| Jun 30, 2014 | -17.99 Mn |
| Mar 31, 2014 | -16.64 Mn |
| Dec 31, 2013 | -1.85 Mn |
| Sep 30, 2013 | -13.87 Mn |
| Jun 30, 2013 | -13.59 Mn |
| Mar 31, 2013 | -10.49 Mn |
| Dec 31, 2012 | -7.73 Mn |
| Sep 30, 2012 | -13.28 Mn |
| Jun 30, 2012 | -8.54 Mn |
| Mar 31, 2012 | -8.90 Mn |
| Dec 31, 2011 | -10.20 Mn |
| Sep 30, 2011 | -6.51 Mn |
| Jun 30, 2011 | -5.29 Mn |
| Mar 31, 2011 | -6.54 Mn |
| Dec 31, 2010 | -7.23 Mn |
| Sep 30, 2010 | -7.56 Mn |
| Jun 30, 2010 | -7.80 Mn |